|
Market Closed -
NYSE
04:00:00 2026-10-23 pm EDT
|
5-day change | 1st Jan Change | ||
| 1.000 USD | +1.52% |
|
+2.22% | -40.12% |
| Sep. 30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| Aug. 07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart: Technical Analysis
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Tradegate
| BT3 | Real-time | |
|
Boerse Muenchen
| BT3 | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 1.07 | 1.14 | 1.35 |
| Spread/Res. | -6.54% | -12.28% | -25.93% |
| Spread/Supp. | +10.59% | +10.59% | +7.49% |
| Support | 0.9042 | 0.9042 | 0.9303 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
